Iguana Healthcare Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | $3.06M | Buy |
60,000
+10,000
| +20% | +$510K | 2.01% | 16 |
|
|
2017
Q4 | $2.32M | Hold |
50,000
| – | – | 1.51% | 25 |
|
|
2017
Q3 | $2.66M | Sell |
50,000
-25,000
| -33% | -$1.33M | 1.45% | 29 |
|
|
2017
Q2 | $4.66M | Hold |
75,000
| – | – | 2.63% | 12 |
|
|
2017
Q1 | $5.08M | Sell |
75,000
-85,000
| -53% | -$5.76M | 2.51% | 10 |
|
|
2016
Q4 | $11.3M | Sell |
160,000
-240,000
| -60% | -$16.9M | 6.72% | 1 |
|
|
2016
Q3 | $28.4M | Buy |
400,000
+260,000
| +186% | +$18.4M | 5.06% | 1 |
|
|
2016
Q2 | $6.85M | Buy |
140,000
+20,000
| +17% | +$978K | 2.79% | 9 |
|
|
2016
Q1 | $7.6M | Buy |
120,000
+5,000
| +4% | +$317K | 2.78% | 10 |
|
|
2015
Q4 | $12.9M | Buy |
115,000
+5,000
| +5% | +$561K | 4.24% | 4 |
|
|
2015
Q3 | $10.6M | Sell |
110,000
-90,000
| -45% | -$8.67M | 4.17% | 3 |
|
|
2015
Q2 | $20.5M | Buy |
200,000
+25,000
| +14% | +$2.56M | 6.46% | 1 |
|
|
2015
Q1 | $10.9M | Buy |
175,000
+125,000
| +250% | +$7.76M | 4.57% | 4 |
|
|
2014
Q4 | $2.19M | Sell |
50,000
-7,500
| -13% | -$329K | 1.06% | 32 |
|
|
2014
Q3 | $3.26M | Buy |
57,500
+15,700
| +38% | +$889K | 1.74% | 15 |
|
|
2014
Q2 | $1.88M | Sell |
41,800
-13,200
| -24% | -$592K | 0.88% | 33 |
|
|
2014
Q1 | $2.69M | Buy |
+55,000
| New | +$2.69M | 1.24% | 22 |
|